ADHD medication dispensing trends in Dutch youth before and after the implementation of the Youth Act (2010-2022).

Publication date: Jun 23, 2025

The Youth Act, implemented by the Dutch government in 2015, aimed to provide more efficient, coherent, and cost-effective care tailored to the specific needs of children, while also reducing medicalization. Between 2003 and 2013, there was a four-fold increase in methylphenidate prescriptions among Dutch children aged 4 to 18 years. However, the impact of the Youth Act on the ADHD medication dispensing remains unassessed. This study investigated changes in ADHD medication dispensing patterns among Dutch youth following the implementation of the Youth Act. A before-after retrospective cohort study was conducted using data from the Dutch community pharmacy-based IADB. nl database among 137,684 youths aged 0-19 years using ADHD medication between 2010 and 2022. A significant decrease in overall ADHD medication dispensing prevalence rates per thousand youths was observed in 2022 compared to 2015 (35. 2 vs. 45. 7, p 

Open Access PDF

Concepts Keywords
Dutch ADHD medication
Medicalization Dosages
Methylphenidate Duration of use
Dutch youth
Incidence
Prevalence
Psychostimulants
Youth Act

Semantics

Type Source Name
disease MESH ADHD
drug DRUGBANK Methylphenidate
drug DRUGBANK Coenzyme M
disease MESH psychiatric disorder
disease MESH impulsivity
disease MESH autism spectrum disorder
disease MESH psychotic disorders
disease MESH anxiety
disease MESH depression

Original Article

(Visited 4 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *